Evaluating a Novel Medication Device for Methadone Dosing

Completed · Not applicable

Conditions studied: Opioid-use Disorder

In brief

This study will evaluate whether a commercially available, secure, electronic pill box is a feasible, acceptable, and satisfactory method to manage take-home dosing of methadone for both methadone clinic patients and staff members.

Key facts

Study ID

NCT03254043

Run by

Johns Hopkins University

People needed

26

Starts

2018-01-31

Expected to finish

2020-03-30

Last updated by the study team

2020-09-28

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Receiving methadone for the treatment of opioid use disorder for at least 90 days and having been on the same methadone dose for at least 30 days
• Have previously received a take-home dose of methadone as part of routine care
• Be willing to comply with the study schedule
• Be a methadone patient in the clinic within which this study is being conducted

You may not qualify if…

• Pregnancy
• Presence of an acute medical problems that requires immediate or intense medical management
• Presence of serious or unstable mental illness that interferes with study procedures
• Planning to leave methadone treatment within the next 12 weeks
• Being maintained on a dose of methadone that is less than 10mg or more than 100mg
• Currently receiving split doses of methadone as part of routine care

Where it is running

• Addiction Treatment Services (ATS) — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.